KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Short-term Investments (2018 - 2025)

Historic Short-term Investments for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $49.4 million.

  • Twist Bioscience's Short-term Investments fell 4.86% to $49.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $49.4 million, marking a year-over-year decrease of 4.86%. This contributed to the annual value of $49.4 million for FY2025, which is 139.37% down from last year.
  • Twist Bioscience's Short-term Investments amounted to $49.4 million in Q4 2025, which was down 4.86% from $49.4 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Short-term Investments registered a high of $166.2 million during Q1 2022, and its lowest value of $12.0 million during Q3 2021.
  • Moreover, its 5-year median value for Short-term Investments was $50.0 million (2023), whereas its average is $75.0 million.
  • Per our database at Business Quant, Twist Bioscience's Short-term Investments tumbled by 9387.07% in 2021 and then skyrocketed by 94936.85% in 2022.
  • Twist Bioscience's Short-term Investments (Quarter) stood at $110.2 million in 2021, then rose by 10.7% to $122.0 million in 2022, then crashed by 63.23% to $44.9 million in 2023, then rose by 10.14% to $49.4 million in 2024, then fell by 0.05% to $49.4 million in 2025.
  • Its last three reported values are $49.4 million in Q4 2025, $49.4 million for Q3 2025, and $49.4 million during Q2 2025.